Find uplifting stories about heroes, innovations, and solutions
8828 results for "weight loss surgery"
Popular weight loss medications are showing an unexpected benefit for people with chronic sinus problems and obesity. A five-year study found patients taking these drugs needed 40% fewer repeat surgeries after sinus operations.
Eli Lilly's experimental obesity medication helped patients lose an average of 28% of their body weight in a major trial, matching results typically seen only with bariatric surgery. The breakthrough treatment offers new hope for millions struggling with obesity, though researchers are working to reduce side effects.
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
A groundbreaking obesity medication helped people lose an average of 70 pounds in clinical trials, matching results previously only seen with bariatric surgery. The drug offers new hope for millions struggling with obesity and related health conditions.
A biotech company just released promising early results for a pill that copies how exercise protects muscle mass while helping people lose weight. Unlike current weight loss drugs, this treatment aims to prevent the muscle loss that happens when people stop and restart medications. #
People using GLP-1 weight loss medications may not need weekly injections forever. A new study shows many patients maintain their weight loss while spacing out doses to every two or even six weeks.
Dr. Abraham Betancourt is transforming lives at Good Samaritan Medical Center through advanced robotic surgery and compassionate patient care. His dual expertise in bariatric and gastrointestinal surgery is helping Florida patients achieve healthier futures.
Postmenopausal women combining hormone therapy with a popular weight loss drug lost 35% more weight than those taking the medication alone. The finding could transform how millions of women manage weight gain after menopause.
Danish scientists discovered that losing weight doesn't just shrink fat cells—it actually helps regenerate healthier fat tissue. The breakthrough research shows that even modest weight loss can reverse obesity-related inflammation and restore fat tissue to a state resembling lean, healthy individuals.
New real-world data shows many patients who stop taking popular weight loss drugs like Wegovy and Zepbound don't quickly regain the weight they lost. The findings challenge earlier concerns that the benefits disappear when treatment ends.
A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.
A groundbreaking medication just moved closer to FDA approval after helping trial participants lose an average of 70 pounds in 80 weeks. The drug matches results typically seen only with surgery, offering new hope for millions struggling with obesity.
A tiny molecule discovered using AI mimics Ozempic's weight loss effects without the nausea, constipation, or muscle loss. Animal studies show the peptide targets only the brain's appetite center, not the entire digestive system.
A promising triple-action medication could help people lose weight without sacrificing muscle. Retatrutide shows potential for safer weight loss with fewer side effects than earlier medications.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
Scientists are testing a breakthrough obesity treatment that helps people lose up to a third of their body weight without sacrificing muscle mass. The triple-action drug retatrutide could solve one of the biggest problems with current weight-loss medications.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
A new diabetes treatment from Eli Lilly helped patients lose 15% of their body weight while improving blood sugar control, potentially becoming the most effective weight loss diabetes drug yet. The results offer hope for millions who struggle to shed pounds while managing their condition.
%2Fhttps%3A%2F%2Ftf-cmsv2-smithsonianmag-media.s3.amazonaws.com%2Ffiler_public%2Ff8%2Ff8%2Ff8f86afc-d21d-40cc-86c9-e212d1e51222%2Fleslie_leinwand_snake_research_0181.jpg)
Scientists discovered an appetite-suppressing molecule in python blood that helped obese mice lose 9% of their body weight without the stomach problems that plague current weight-loss drugs. This breakthrough could lead to a new generation of treatments inspired by nature's most extreme fasters.
Showing 20 of 8828